Live Cell Imaging Market Worth $5.45 Billion by 2019

DALLAS, May 12, 2015 /PRNewswire/ --

According to a new market research report "Live Cell Imaging Market by Product (Equipment, Consumables, Software), by Technology (Fluorescence Recovery after Photobleaching, High-Content Screening), by Application (Cell Biology, Stem Cells, Drug Discovery) - Analysis & Global Forecast to 2019 ", published by MarketsandMarkets,  the Live Cell Imaging Market was valued at $3.57 Billion in 2014  and is expected to reach around $5.45 Billion by 2019 with a CAGR of around 8.8% during the forecast period from 2014 to 2019.

Browse 128 market data Tables and 57Figures spread through 219Pages and in-depth TOC on "Live Cell Imaging Market"

http://www.marketsandmarkets.com/Market-Reports/live-cell-imaging-market-163914483.html

Early buyers will receive 10% customization on this report.

Factors driving live cell imaging market include adoption of high-content screening techniques in drug discovery, rising incidence of cancer worldwide, and government funding in cell-based research. However, factors such as high cost of high-content screening systems and shortage of knowledgeable and skilled professionals are hindering the growth of this market.

Inquiry before Buying:http://www.marketsandmarkets.com/Enquiry_Before_Buying.asp?id=163914483

The global Live Cell Imaging Market is segmented on the basis of products, technologies, applications, and regions.

Based on products, the live cell imaging market is categorized into equipment, consumables, and software. In 2014, the equipment segment accounted for a major share of the live cell imaging market. On the basis of equipment, the live cell imaging market is further segmented into microscopes, standalone systems, cell analyzers, and image-capturing devices. In 2014, the microscopy segment accounted for the largest share of the live cell imaging equipment market. Based on consumables, the live cell imaging market is segmented into assay kits, reagents, media, and others. In 2014, the assay kits segment accounted for the largest share of the consumables market.

Based on technologies, the live cell imaging market is segmented into fluorescence resonance energy transfer (FRET), fluorescence in situ hybridization (FISH), high-content analysis (HCA), fluorescence recovery after photobleaching (FRAP), ratiometric imaging, total internal reflection fluorescence microscopy (TRIF), multiphoton excitation microscopy (MPE), and other technologies.

Based on applications, the live cell imaging market is segmented into cell biology, stem cells, developmental biology, and drug discovery. In 2014, the cell biology segment accounted for the largest share of live cell imaging market.

On the basis of regions, the market is divided into North America, Europe, Asia, and the Rest of the World (RoW). The Rest of the World region comprises Latin America, Pacific countries, and the Middle East and Africa. In 2014, North America accounted for the largest share of the live cell imaging market, followed by Europe and Asia.

Some of the major players in the global Live Cell Imaging Market include Carl Zeiss AG (Germany), Leica Microsystems (Germany), Nikon Corporation (Japan), Molecular Devices, LCC (U.S.), PerkinElmer, Inc. (U.S.), GE Healthcare (U.K.), Becton, Dickinson and Company (U.S.), Olympus Corporation (Japan), Sigma-Aldrich Corporation (U.S.), and Thermo Fisher Scientific, Inc. (U.S.).

Browse Related Reports: 

High Content Screening Market by Instruments (Cell Imaging and Analysis System), by Applications (Primary and Secondary Screening, Target Identification and Validation, Toxicity Studies, Compound Profiling), Software & Services - Global Forecasts to 2018

http://www.marketsandmarkets.com/Market-Reports/high-content-screening-market-42710391.html

Cell-based Assays Market by Product [Reagents & Assay Kits (Cytotoxicity, GPCR), Cell lines, Plate Readers, HCS, HTS, Software & Assay Development Services], Application (Drug Discovery, ADMET), End-user (Pharmaceutical, CRO) - Global Forecast to 2018

http://www.marketsandmarkets.com/Market-Reports/cell-based-assays-market-119917269.html

About MarketsandMarkets 

MarketsandMarkets is world's No. 2 firm in terms of annually published premium market research reports. Serving 1700 global fortune enterprises with more than 1200 premium studies in a year, M&M is catering to multitude of clients across 8 different industrial verticals. We specialize in consulting assignments and business research across high growth markets, cutting edge technologies and newer applications. Our 850 fulltime analyst and SMEs at MarketsandMarkets are tracking global high growth markets following the "Growth Engagement Model - GEM". The GEM aims at proactive collaboration with the clients to identify new opportunities, identify most important customers, write "Attack, avoid and defend" strategies, identify sources of incremental revenues for both the company and its competitors.

M&M's flagship competitive intelligence and market research platform, "RT" connects over 200,000 markets and entire value chains for deeper understanding of the unmet insights along with market sizing and forecasts of niche markets. The new included chapters on Methodology and Benchmarking presented with high quality analytical infographics in our reports gives complete visibility of how the numbers have been arrived and defend the accuracy of the numbers.

We at MarketsandMarkets are inspired to help our clients grow by providing apt business insight with our huge market intelligence repository.

Subscribe Reports from Healthcare Domain@http://www.marketsandmarkets.com/Subscription.html

Contact: 

Mr. Rohan
North - Dominion Plaza,
17304, Preston Road,
Suite 800, Dallas, TX 75252
Tel: +1-888-600-6441
Email: sales@marketsandmarkets.com
Visit MarketsandMarkets Blog @ http://mnmblog.org/market-research/healthcare/biotechnology
Connect with us on LinkedIn @ http://www.linkedin.com/company/marketsandmarkets